Exhibit 99.1
IDEX Biometrics ASA Announces Effectiveness of Voluntary Delisting of ADSs from Nasdaq Stock Market
Oslo, Norway, August 10, 2023 IDEX Biometrics ASA (IDEX or the Company)
(Nasdaq: IDBA), a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control and digital identity, today announces that the Companys voluntary delisting of American Depositary Shares
(ADSs) representing its ordinary shares from The Nasdaq Capital Market (Nasdaq) has become effective. Each ADS represents 75 ordinary shares of the Company. The Company has also filed a Form 15 with the Securities and
Exchange Commission (SEC) to suspend its reporting obligations under the Securities Exchange Act of 1934, as amended (the Exchange Act), in respect of the ADSs and the ordinary shares. The Company expects that the
deregistration of the ADSs under the Exchange Act will become effective 90 days after the filing of the Form 15.
Information for ADS Holders
The Bank of New York Mellon serves as depositary (the Depositary) for the Companys ADS facility. Each ADS represents 75 of our ordinary
shares. The Depositary intends to terminate the Deposit Agreement, dated February 26, 2021, among us, the Depositary and owners and holders of ADSs (the Deposit Agreement) on October 19, 2023.
Under the terms of the Deposit Agreement, ADS holders have until at least October 19, 2023 to surrender ADSs for delivery of the underlying ordinary
shares. If you surrender ADSs for delivery of the underlying shares, you must pay a cable fee of $17.50. In order to exchange ADSs for the Companys ordinary shares, ADS holders should instruct their brokers to surrender ADSs to The Bank of New
York Mellon (DTC No. 2504). In connection with this surrender, brokers should include ongoing ordinary share delivery instructions in the comments field within DTC, including information such as the name and BIC of the appropriate local
bank/broker and/or appropriate delivery code, beneficiary name and account number. U.S. brokers holding ADSs on behalf of their clients, can reach out to DRSettlements@BNYMellon.com for questions regarding the conversion and settlement process.
Subsequent to October 19, 2023, the Depositary may elect to sell the underlying shares. If the Depositary has sold such shares, holders of ADSs must
surrender such securities in order to obtain payment of the sale proceeds of the underlying ordinary shares, net of the expenses of sale, any applicable U.S. or local taxes or government charges and a cancellation fee of up to $0.05 per ADS.
To surrender ADSs, the address of the Depositary is: The Bank of New York Mellon, 240 Greenwich Street, Depositary Receipts Division 8th Floor,
Attention: Cancellation Desk, New York, NY 10286. Registered or overnight mail is the suggested method of delivering ADSs to the Depositary. For Settlement specific inquiries, please contact DRsettlements@bnymellon.com.
Investors may still present ADSs to The Bank of New York Mellon. Investors will receive either the underlying shares (if those have not yet been sold by the
Depositary) or the cash received by the Depositary received upon sale of underlying shares, net of fees, if those underlying shares were sold. For more information, investors should contact DRBrokerSolutions@bnymellon.com.
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and
Nasdaq: IDBA) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and
1